Results 1 to 1 of 1
07-31-2010, 12:10 AM #1
Lundbeck Inc. Announces the Voluntary Nationwide Recall of Two Lots of NeoProfen® (ib
– Lundbeck Inc. has voluntarily recalled two lots of NeoProfen® (ibuprofen lysine) Injection that failed to meet a visible particulate quality requirement. These two lots are the only lots currently available to prescribers and therefore the recall will result in a temporary drug shortage. This voluntary recall is the result of the company’s inspections of the two product lots of NeoProfen.